Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medpace Holdings, Inc. - Common Stock (NQ: MEDP )

317.93 -6.98 (-2.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Earnings Outlook For Medpace Hldgs
Medpace Hldgs (NASDAQ:MEDP) is set to give its latest quarterly earnings report on Monday, 2021-10-25. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
Medpace Hldgs Insider Trades $12 Million In Company Stock
Susan E Burwig, Exec. Vp And Operations at Medpace Hldgs (NASDAQ:MEDP), made a large insider sell on September 3, according to a new SEC filing. What Happened: A Form 4 filing... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc... 
Via Benzinga
Exposures Product Safety
Stocks That Hit 52-Week Highs On Thursday
Thursday morning saw 166 companies set new 52-week highs. Interesting Highlights: The largest company by market cap to hit a new 52-week high was Microsoft (NASDAQ:... 
Via Benzinga
Medpace Holdings, Inc. to Report Third Quarter 2021 Financial Results on October 25, 2021
From Medpace Holdings, Inc.
Via Business Wire
Medpace Stock Earns Relative Strength Rating Upgrade; Remains In Buy Zone
Ohio-based Medpace stock saw its Relative Strength Rating enter the 80-plus level while it stays in a buy zone. 
Via Investor's Business Daily
Medpace Holdings, Inc. to Present at Baird’s Global Healthcare Conference
From Medpace Holdings, Inc.
Via Business Wire
A Look Into Medpace's Price Over Earnings
In the current market session, Medpace Hldgs Inc. (NASDAQ:MEDP) is trading at $179.28, after a 0.76% drop. However, over the past month, the stock increased by 2.01... 
Via Benzinga
Medpace Stock Shows Rising Price Performance With Jump To 83 RS Rating
Medpace sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
Medpace Holdings, Inc. Common Stock (MEDP) Q2 2021 Earnings Call Transcript
MEDP earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Medpace Hldgs: Q2 Earnings Insights
Shares of Medpace Hldgs (NASDAQ:MEDP) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 65.62% year over year... 
Via Benzinga
Medpace Holdings, Inc. Announces Senior Leadership Changes
From Medpace Holdings, Inc.
Via Business Wire
Medpace Holdings, Inc. Reports Second Quarter 2021 Results
From Medpace Holdings, Inc.
Via Business Wire
Earnings Outlook For Medpace Hldgs
Medpace Hldgs (NASDAQ:MEDP) announces its next round of earnings this Monday, July 26. Here is Benzinga's everything-that-matters guide for this Monday's Q2 earnings announcement... 
Via Benzinga
Earnings Scheduled For July 26, 2021
Companies Reporting Before The Bell • Otis Worldwide (NYSE:OTIS) is estimated to report quarterly earnings at $0.71 per share on revenue of $3.45 billion. •... 
Via Benzinga
Medpace Holdings, Inc. to Report Second Quarter 2021 Financial Results on July 26, 2021
From Medpace Holdings, Inc.
Via Business Wire
3 Top Healthcare Stocks to Buy Right Now
These three healthcare stocks have proven that growth and long-term trends are on their side. 
Via The Motley Fool
Medpace Holdings, Inc. to Present at the Jefferies Virtual Healthcare Conference
From Medpace Holdings, Inc.
Via Business Wire
Cramer Advises Viewers On Fastly, Wells Fargo And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he expects more downgrades for Fastly Inc (NYSE: FSLY) on Thursday. He can't recommend the stock. Cramer... 
Via Benzinga
52 Biggest Movers From Yesterday
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) gained 51.2% to close at $24.90 on Tuesday. Urban Tea, Inc. (NASDAQ: MYT) rose 38.1% to settle at $4.64. Vaxart, Inc. (... 
Via Benzinga
Medpace Holdings, Inc. Common Stock (MEDP) Q1 2021 Earnings Call Transcript
MEDP earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
38 Stocks Moving In Tuesday's Mid-Day Session
Gainers RiceBran Technologies (NASDAQ: RIBT) shares jumped 60.8% to $1.4950. RiceBran Technologies is scheduled to host a conference call on April 28th to discuss its Q1... 
Via Benzinga
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Medpace Holdings, Inc. Reports First Quarter 2021 Results
From Medpace Holdings, Inc.
Via Business Wire
Three Medical Stocks To Watch, Including One With A Potential Breakout
Two have recent breakouts under their belts while a third is eyeing a fresh buy point. 
Via Investor's Business Daily
Earnings Scheduled For April 26, 2021
Companies Reporting Before The Bell • Albertsons Companies (NYSE:ACI) is projected to report quarterly earnings at $0.51 per share on revenue of $15.63 billion.... 
Via Benzinga
The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:... 
Via Benzinga
Medpace Holdings Stock At The Top Of Buy Range With Earnings On Deck
Medpace is in a potential buy range with its next earnings report scheduled for Apr. 26. The medical stock is about 3% above a 177.22 buy point from a second-stage... Read More 
Via Investor's Business Daily
The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Ardelyx, Inc. (NASDAQ:... 
Via Benzinga
The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
Exposures COVID-19
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.